• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Antibody Drug Discovery Companies

    ID: MRFR/HC/10534-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Antibody drug discovery companies spearhead innovation in developing therapeutic antibodies, revolutionizing medical treatments. Utilizing cutting-edge technologies, these firms engineer antibodies tailored to target specific diseases, offering precision medicine solutions. Employing phage display, hybridoma, and recombinant DNA techniques, they identify and optimize antibodies with exceptional binding affinity. These companies often collaborate with pharmaceutical giants, utilizing their expertise in monoclonal antibody development for diverse applications, including cancer immunotherapy, autoimmune disorders, and infectious diseases. 

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Antibody Drug Discovery Market Research Report—Global Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Antibody Drug Discovery Market

    Antibody Drug Discovery Key Companies

     


    Latest Antibody Drug Discovery Companies Update:

    WuXi AppTec (SHA: 603255), a leading global CRO and CDMO, acquired '''AbCellera''' in June 2023, bolstering its antibody discovery capabilities and geographic reach.


    Abcam (AIM: ABCM), a life sciences tools provider, partnered with '''Sano Genetics''' in December 2023 to develop novel antibody libraries for therapeutic discovery.


    Bio-Techne Corporation (NASDAQ: TECH), a provider of life science reagents and instruments, acquired '''Proteintech Group''' in November 2023, gaining access to Proteintech's extensive antibody portfolio for research and development.


    AbCellera unveiled its 'ACE Discovery Engine', a next-generation antibody discovery platform utilizing machine learning and AI, in July 2023.


    MorphoSys (MOR: XTRA) showcased its 'FastTrack' discovery technology, capable of rapidly generating high-quality antibody leads, at the ESMO Congress in September 2023.


    Sanyou Biopharmaceuticals (SZSE: 002234) launched its 'Sanyou Super Trillion Common Light Chain Antibody Discovery Platform' in June 2023, enabling efficient discovery of bispecific antibody formats.


    List of Antibody Drug Discovery Key companies in the market

    • Charles River Laboratories (US)

    • Biocytogen Pharmaceuticals Co., Ltd (China)

    • Sartorius AG (Germany)

    • Genscript Biotech Corporation (US)

    • Creative Biolabs (US)

    • Twist Bioscience (US)

    • Fairjourney Biologics SA (Portugal)

    • ProteoGenix (US)

    • Absolute Antibody (UK)

    • Sino Biological, Inc. (China)